Aquarray GmbHMicroarray technology for personalised medicine
After having received funding from the European Union's SME Instrument, the Eggenstein-Leopoldshafen-based start-up, Aquarray, is pushing ahead with the further development of its droplet microarray technology into a personalised medicine application. The technology enables cell experiments to be performed at high density with low cell numbers. With small cell quantities, a large number of screenings can be performed without additional laboratory automation and without pipetting, thus saving costs and resources.
As key account managers, Steinbeis 2i senior experts assessed innovation management capacities and identified different coaching options for Aquarray. Since summer 2020, Steinbeis 2i has been supporting the administrative and financial project management of the EU project "Droplet Microarray".
„To meet the requirements of EU funding, we need to fully understand the various specifications and tools of the EU. As a small start-up, it is very difficult to do this. Therefore, the professional support that Steinbeis 2i offers through their expertise is essential for us.“Dr. Wolfgang Sipos, CEO AQUARRAY GmbH